Stock Rich List
Nasdaq: VIR

Vir Biotechnology insiders

The officers, directors and 10% owners of Vir Biotechnology, Inc. who hold the most stock, valued at the live VIR price.

$8.87
VIR today −$280K (−3.06%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
8
Their VIR stock
$155M
Market value
$1.65B
Held by ranked insiders
9.38%

Insiders by value of VIR holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1ARCH Venture Fund IX, L.P.10% owner6,144,428$54.5M3.30%Corporate
2ARCH Venture Partners IX, L.P.10% owner5,717,738$50.7M3.07%Corporate
3George A. ScangosDirector2,661,798$23.6M1.43%3690th
4Vicki L. SatoDirector1,078,391$9.6M0.58%7843rd
5Backer Marianne DePresident and CEO1,054,381$9.4M0.57%8333rd
6Robert NelsenDirector618,041$5.5M0.33%13445th
7Phillip A. SharpDirector165,618$1.5M<0.1%2946th
8Ramy FaridDirector32,000$284K<0.1%8182nd

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Vir Biotechnology; see each profile for the filing.